Telcon RF Pharmaceutical Overview

  • Founded
  • 1999

Founded
  • Status
  • Public

  • Employees
  • 131

Employees
  • Stock Symbol
  • 200230

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.75

  • (As of Friday Closing)

Telcon RF Pharmaceutical General Information

Description

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Electrical Equipment
Other Industries
Connectivity Products
Fiberoptic Equipment
Stock Exchange
KRX
Primary Office
  • 54, Gongse-ro
  • Giheung-gu
  • Yongin-si, Gyeonggi-do
  • South Korea
+82 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Telcon RF Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.75 $0.75 $0.71 - $3.37 $81.6M 109M 232K -$0.56

Telcon RF Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 135,746 273,106 544,519 355,679
Revenue 26,394 33,037 28,069 45,004
EBITDA (46,371) (9,620) (29,189) (41,787)
Net Income (52,907) (20,166) (34,635) (47,004)
Total Assets 104,481 141,199 169,630 111,785
Total Debt 25,099 47,004 80,956 10,508
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Telcon RF Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request a free trial

Telcon RF Pharmaceutical Patents

Telcon RF Pharmaceutical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018101542-A6 Hybrid connector Active 16-Oct-2018 0000000000
AU-2018101542-A4 Hybrid connector Active 16-Oct-2018 0000000000
AU-2017363816-A1 Multiport cable terminal Active 28-Nov-2016 0000000000
AU-2017363816-B2 Multiport cable terminal Active 28-Nov-2016 0000000000
AU-2017366073-B2 Rotatable connector Active 28-Nov-2016 H01R35/00
To view Telcon RF Pharmaceutical’s complete patent history, request access »

Telcon RF Pharmaceutical Executive Team (1)

Name Title Board Seat Contact Info
Jin-hun Lim Chief Executive Officer and President
To view Telcon RF Pharmaceutical’s complete executive team members history, request access »

Telcon RF Pharmaceutical Board Members (1)

Name Representing Role Since
0000-0000 00 Telcon RF Pharmaceutical Board Member 000 0000
To view Telcon RF Pharmaceutical’s complete board members history, request access »

Telcon RF Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Telcon RF Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request a free trial

Telcon RF Pharmaceutical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Aug-2016 000000000 000.00 Drug Discovery
To view Telcon RF Pharmaceutical’s complete investments history, request access »